Ljunggren B, Wirestrand L E
Department of Dermatology and Experimental Research, Lund University, Malmö General Hospital, Sweden.
Photodermatol. 1988 Jun;5(3):133-8.
Clinical photoreactions have been reported for quinine and quinidine after systemic and topical administration. We have investigated the phototoxic properties of these two quinoline methanol isomers in vitro using the Candida albicans inhibition test and photohemolysis, and in vivo with the mouse tail phototoxicity test. Both isomers were phototoxic in the hemolysis model, quinine being the more potent compound. In the Candida test only quinidine was phototoxically active. In the mouse tail model, measuring edema, the phototoxic activity of quinidine was comparatively low, causing a 7.3% wet weight increase of tail tissue at a dose of 150 mg/kg intraperitoneally of drug and 54 J/cm2 of UVA. In spite of its structural similarity to quinidine, quinine was not phototoxic in the mouse. These studies support the assumption, based on clinical data, that quinine photoreactions probably have a non-phototoxic mechanism. For quinidine, however, light-induced reactions based on phototoxicity can not be ruled out, since low-grade phototoxic properties were demonstrated in vivo.
全身给药和局部给药后,已有关于奎宁和奎尼丁临床光反应的报道。我们使用白色念珠菌抑制试验和光溶血试验在体外研究了这两种喹啉甲醇异构体的光毒性特性,并通过小鼠尾巴光毒性试验在体内进行了研究。两种异构体在溶血模型中均具有光毒性,奎宁是活性更强的化合物。在念珠菌试验中,只有奎尼丁具有光毒性活性。在小鼠尾巴模型中,测量水肿情况,奎尼丁的光毒性活性相对较低,腹腔注射剂量为150mg/kg药物和54J/cm²紫外线A时,尾巴组织湿重增加7.3%。尽管奎宁与奎尼丁结构相似,但在小鼠中它没有光毒性。这些研究支持基于临床数据的假设,即奎宁光反应可能具有非光毒性机制。然而,对于奎尼丁,由于在体内证明了其低度光毒性特性,不能排除基于光毒性的光诱导反应。